Stuart M. Sloan Sells 532,486 Shares of CERo Therapeutics Holdings, Inc. (NASDAQ:CERO) Stock

CERo Therapeutics Holdings, Inc. (NASDAQ:CERO) major shareholder Stuart M. Sloan sold 532,486 shares of CERo Therapeutics stock in a transaction dated Wednesday, September 25th. The stock was sold at an average price of $0.10, for a total transaction of $53,248.60. Following the completion of the sale, the insider now owns 21,067,956 shares of the company’s stock, valued at $2,106,795.60. This trade represents a 2.47 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Major shareholders that own 10% or more of a company’s stock are required to disclose their transactions with the SEC.

CERo Therapeutics Trading Down 2.5 %

NASDAQ CERO opened at $0.24 on Friday. The company has a 50 day moving average of $0.11 and a 200-day moving average of $0.32. CERo Therapeutics Holdings, Inc. has a 1-year low of $0.06 and a 1-year high of $12.80.

About CERo Therapeutics

CERo Therapeutics Holdings, Inc, an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead program in hematologic malignancies targets an Eat Me signal upregulated on B cell and myeloid tumors. The company is based in South San Francisco, California.